RegenETP, Inc. (RGTPQ)
OTCMKTS · Delayed Price · Currency is USD
0.1600
0.00 (0.00%)
Apr 3, 2025, 4:00 PM EST

RegenETP Company Description

RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States.

The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services.

The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products.

The company was formerly known as PolarityTE, Inc. and changed its name to RegenETP, Inc. in August 2023.

RegenETP, Inc. is headquartered in Salt Lake City, Utah.

RegenETP, Inc.
Country United States
Industry Biotechnology
Sector Healthcare
Employees 43
CEO Richard Hague

Contact Details

Address:
1960 South 4250 West
Salt Lake City, Delaware 84104
United States
Phone 800 560 3983
Website polaritybio.com

Stock Details

Ticker Symbol RGTPQ
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
SIC Code 2836

Key Executives

Name Position
Richard Hague President, Chief Executive Officer and Director
Nikolai Sopko M.D., Ph.D. Chief Operating Officer and Chief Scientific Officer
Rich Haerle Vice President of Investor Relations and Strategy
Mark E. Lehman J.D. Chief Legal Officer
Angela Ziegler Vice President of Marketing and Public Relations
Alain Adam Vice President of Sales
Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D. Senior Vice President of Corporate Development and President of Contract Services
Ryan Mathis M.D. Chief Medical Officer
Kolby Day Esq. Senior Vice President of Manufacturing Operations